Why World Health Organization: 5 to 11 year olds can get Pfizer-Bioentech vaccine

The World Health Organization's advisory panel on Friday recommended that a small dose of the Pfizer - Biontech Covid-19 vaccine be given to children between the ages of 5 and 11.

The company's vaccine was evaluated after a meeting of experts from the World Health Organization's Strategic Advisory Group on Strategic Immunization this week.

During a virtual briefing on Friday, SAGE Chairman Alejandro Cravioto told reporters that the committee believes that 5-11 year olds should be given less priority in vaccination. However, only those children who already have a health problem should be vaccinated first on a priority basis.

The recommended dose for the younger population is 10 micrograms instead of 30 micrograms.

Cravioto said the panel further recommended that adults should receive a booster dose 4 to 6 months after receiving the Pfizer - Biontech Covid-19 vaccine. He said the elderly, along with health and other frontline workers, should be given priority for boosters.

The World Health Organization's advisory panel on Friday recommended that a small dose of the Pfizer - Biontech Covid-19 vaccine be given to children between the ages of 5 and 11.

The company's vaccine was evaluated after a meeting of experts from the World Health Organization's Strategic Advisory Group on Strategic Immunization this week.

During a virtual briefing on Friday, SAGE Chairman Alejandro Cravioto told reporters that the committee believes that 5-11 year olds should be given less priority in vaccination. However, only those children who already have a health problem should be vaccinated first on a priority basis.

The recommended dose for the younger population is 10 micrograms instead of 30 micrograms.

Cravioto said the panel further recommended that adults should receive a booster dose 4 to 6 months after receiving the Pfizer - Biontech Covid-19 vaccine. He said the elderly, along with health and other frontline workers, should be given priority for boosters.

The World Health Organization's advisory panel on Friday recommended that a small dose of the Pfizer - Biontech Covid-19 vaccine be given to children between the ages of 5 and 11.

The company's vaccine was evaluated after a meeting of experts from the World Health Organization's Strategic Advisory Group on Strategic Immunization this week.

During a virtual briefing on Friday, SAGE Chairman Alejandro Cravioto told reporters that the committee believes that 5-11 year olds should be given less priority in vaccination. However, only those children who already have a health problem should be vaccinated first on a priority basis.

The recommended dose for the younger population is 10 micrograms instead of 30 micrograms.

Cravioto said the panel further recommended that adults should receive a booster dose 4 to 6 months after receiving the Pfizer - Biontech Covid-19 vaccine. He said the elderly, along with health and other frontline workers, should be given priority for boosters.

The World Health Organization's advisory panel on Friday recommended that a small dose of the Pfizer - Biontech Covid-19 vaccine be given to children between the ages of 5 and 11.

The company's vaccine was evaluated after a meeting of experts from the World Health Organization's Strategic Advisory Group on Strategic Immunization this week.

During a virtual briefing on Friday, SAGE Chairman Alejandro Cravioto told reporters that the committee believes that 5-11 year olds should be given less priority in vaccination. However, only those children who already have a health problem should be vaccinated first on a priority basis.

The recommended dose for the younger population is 10 micrograms instead of 30 micrograms.

Cravioto said the panel further recommended that adults should receive a booster dose 4 to 6 months after receiving the Pfizer - Biontech Covid-19 vaccine. He said the elderly, along with health and other frontline workers, should be given priority for boosters.

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.